CHELATEC

About CHELATEC

CHELATEC sits in Other / Uncategorized, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Imaging Wire · 2026-09-16
  Chelatec closes Series C round to scale radiopharma manufacturing
  Coverage notes the company's growing footprint in the radioligand therapy space.
• STAT News · 2026-02-27
  Chelatec publishes dosimetry data at SNMMI 2026
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Nuclear Medicine Today · 2026-03-02
  Chelatec files IND for next-generation PSMA-targeted agent
  Coverage notes the company's growing footprint in the radioligand therapy space.
• PR Newswire · 2026-04-25
  Chelatec partners with academic center on Actinium-225 program
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.